Prezista or Darunavir, the newest anti-AIDS drug seems to be effective in patients who have exhausted all modes of treatment in fighting their resistant HIV virus.
Scientists at the 16th International AIDS Conference said 46% of the patients who received Prezista along with background medication suppressed the virus to levels that were hardly detectable following 48 weeks of treatment
